ystral was able to support the Waisenmedizin e.V. in the technical challenge of producing a medical gel for the treatment of leishmaniasis: in the conventional mixing process air is injected into the gel so that the wound to be treated is not sealed airtight. Therefore, a downstream degassing of the product would have to take place which however evaporates an active ingredient and makes the manufactured product ineffective.
Process plant for the fabrication of pharmaceutical gel
- Industry:
- Pharmaceutical industry
- End product:
Wound-healing gel
- Application:
Dispersing sodium chlorite and fillers in water
The customer requirements:
- Batch size: max. 10 l/Charge
- Space requirement: 9 m³
- Degree of automation: manual operation
- Powder feed: Powder hopper 20 l
- Cleanability: Wash in place (WIP) / manual
Advantages compared to the previous process
During mixing of the solid and liquid ingredients air was introduced in the conventional process. These air entrapments avoided the "mechanical" effect of the gel which is why a downstream degassing process was necessary. In the degassing process an active ingredient evaporates, making the gel also ineffective.
- No air entry into the product scale-up from small quantities to production scale possible
- Laboratory scale batch sizes from 3l
- Maximum raw material utilization
- Minimum residual quantities
- All process parts can be easily dismantled for cleaning
- GMP compliant
- Licence to produce medical products/pharmaceuticals in a pharmacy
